Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HANGER, INC. | SVP, Chief Clinical Officer | Common Stock | 0 | $18.75 | Oct 3, 2022 | Direct | |
HANGER, INC. | SVP, Chief Clinical Officer | Stock Options (right to buy) | 0 | $5.98 | Oct 3, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HNGR | HANGER, INC. | Oct 3, 2022 | 3 | -$1.15M | 4 | Oct 4, 2022 | SVP, Chief Clinical Officer |
HNGR | HANGER, INC. | Mar 9, 2022 | 1 | -$25K | 4 | Mar 11, 2022 | SVP, Chief Clinical Officer |
HNGR | HANGER, INC. | Mar 8, 2022 | 1 | -$34.6K | 4 | Mar 10, 2022 | SVP, Chief Clinical Officer |
HNGR | HANGER, INC. | Mar 7, 2022 | 2 | -$78.1K | 4 | Mar 8, 2022 | SVP, Chief Clinical Officer |
HNGR | HANGER, INC. | Feb 15, 2022 | 1 | $0 | 4 | Feb 16, 2022 | SVP, Chief Clinical Officer |